The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece
- 10 May 2005
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 222 (1) , 57-65
- https://doi.org/10.1016/j.canlet.2004.11.025
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The Common 677C>T Gene Polymorphism of Methylenetetrahydrofolate Reductase Gene is not Associated with Breast Cancer RiskBreast Cancer Research and Treatment, 2003
- TP53and breast cancerHuman Mutation, 2003
- Evidence against involvement of p53 polymorphism in breast cancer predispositionInternational Journal of Cancer, 2002
- Ethnic variation in the HER-2 codon 655 genetic polymorphism previously associated with breast cancerJournal of Human Genetics, 2002
- Distribution of HER2V655 genotypes in breast cancer cases and controls in the United StatesCancer Letters, 2001
- Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish womenEuropean Journal Of Cancer, 2000
- p53 Codon 72 Polymorphism as a Risk Factor in the Development of Breast CancerMolecular Cell Biology Research Communications, 2000
- Population-Based, Case-Control Study of HER2 Genetic Polymorphism and Breast Cancer RiskJNCI Journal of the National Cancer Institute, 2000
- p53 polymorphisms and haplotypes in breast cancerCarcinogenesis: Integrative Cancer Research, 1996
- Mutations in p53 as potential molecular markers for human breast cancer.Proceedings of the National Academy of Sciences, 1991